Jon Sabes, CEO of GWG Holdings’ Insurtech Subsidiary Life Epigenetics, to Speak at Plug and Play Innovation Event
December 04 2017 - 5:05PM
Life Epigenetics, the insurtech subsidiary of GWG Holdings,
Inc. (Nasdaq:GWGH), announced that its chief executive
officer, Jon Sabes, will speak at the Best Practices event on
Innovation sponsored by Plug And Play in Sunnyvale, CA on Tuesday,
Dec. 5.
Sabes will speak at the daylong program for the corporate
partners of Plug and Play, an accelerator and venture fund based in
Silicon Valley.
“This is part of our strategy of telling our story to a wider
audience of companies in the insurance industry.” Sabes said. “We
want to build on the excitement we have been generating and the
Plug and Play event is a great place to do it.”
Life Epigenetics holds the exclusive license for
lifespan-predictive technology developed at the University of
California, Los Angeles (UCLA) for the life insurance industry.
Since February the company has been collecting and analyzing data
from life insurance policyholders and has been discussing its
work with major life insurance and reinsurance companies that have
expressed interest in learning more about how the technology can
add value to their businesses. In October, it has announced
pilot programs with two life insurance companies to test its
epigenetic-based M-Panel technology.
About Life Epigenetics
Life Epigenetics is the insurtech subsidiary of GWG Holdings,
Inc. (Nasdaq:GWGH) that is dedicated to creating new technology
that is transformative to the way life insurance and financial
services underwrite and deliver longevity-based products and
services. The company’s “DNA methylation-based predictor of
mortality technology,” exclusively licensed from the University of
California, Los Angeles (UCLA), provides unprecedented new insight
into longevity using the cutting edge science of epigenetics.
For more information about Life Epigenetics, Inc.,
visit www.lifeegx.com
About GWG Holdings, Inc.
GWG Holdings, Inc. (Nasdaq:GWGH) is a financial services company
committed to transforming the life insurance industry through
disruptive and innovative products and services. The company owns
Life Epigenetics and GWG Life. GWG Life is developing a suite of
new longevity-based products for consumers and financial advisors
under the LifeCare Xchange (LCX). The LifeCare Xchange provides
consumers owning life insurance with the opportunity to exchange
their life insurance into products that can be used to pay for
long-term care and meet other retirement financial needs. Life
Epigenetics is developing transformative M-Panel epigenetic
technology to disrupt traditional life insurance underwriting
practices. Since 2006, GWG Life has provided seniors over $436
million in exchange value for their life insurance and, as of June
30, 2017, owns a portfolio of over $1.5 billion in face value of
policy benefits.
For more information about GWG Holdings, Inc.
email info@gwglife.com or visit www.gwgh.com.
Attachments:
A photo accompanying this announcement is available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/9bb8177c-a708-409a-8f41-66af93cbd346
Attachments:
A photo accompanying this announcement is available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/a1d4017e-e638-413a-aa8a-74c649a6c2c5
Daniel T Callahan
GWG Life
612-746-1935
callahad@gmail.com
GWG (NASDAQ:GWGH)
Historical Stock Chart
From Mar 2024 to Apr 2024
GWG (NASDAQ:GWGH)
Historical Stock Chart
From Apr 2023 to Apr 2024